Search

An extractive spectrophotometric analytical method has been developed for the determination of uranium in ore leach solution. This technique is based on the selective extraction of uranium from multielement system using a synergistic mixture of 2-ethylhexyl phosphonic acid-mono-2-ethylhexyl ester (PC88A) and tri-n-octyl phosphine oxide (TOPO) in cyclohexane and color development from the organic phase aliquot using 2-(5-Bromo-2-pyridylazo)-5-diethyl aminophenol (Br-PADAP) as chromogenic reagent. The absorption maximum (λ(max)) for UO(2)(2+)-Br-PADAP complex in organic phase samples, in 64% (v/v) ethanol containing buffer solution (pH 7.8) and 1,2-cyclohexylenedinitrilotetraacetic acid (CyDTA) complexing agent, has been found to be at 576 nm (molar extinction coefficient, ɛ: 36,750 ± 240 L mol(-1)cm(-1)). Effects of various parameters like stability of complex, ethanol volume, ore matrix, interfering ions etc. on the determination of uranium have also been evaluated. Absorbance measurements as a function of time showed that colored complex is stable up to > 24h. Presence of increased amount of ethanol in colored solution suppresses the absorption of a standard UO(2)(2+)-Br-PADAP solution. Analyses of synthetic standard as well as ore leach a solution show that for 10 determination relative standard deviation (RSD) is < 2%. The accuracy of the developed method has been checked by determining uranium using standard addition method and was found to be accurate with a 98-105% recovery rate. The developed method has been applied for the analysis of a number of uranium samples generated from uranium ore leach solutions and results were compared with standard methods like inductively coupled plasma emission spectrometry (ICPAES). The determined values of uranium concentrations by these methods are within ± 2%. This method can be used to determine 2.5-250 μg mL(-1) uranium in ore leach solutions with high accuracy and precision., (Copyright © 2012 Elsevier B.V. All rights reserved.)

The effect of subzero temperatures on the electrophoretic pattern of seminal plasma protein of cattle and buffalo was studied. The profiles of the seminal proteins of these two closely related species differed considerably. Cattle had 11 proteins in the anodic system (pH 8.6) and none in the cathodic system (pH 4.3), while buffalo have 19 in the anodic system (pH 8.6) and 2 proteins in the cathodic system (pH 4.3). Freezing of semen at -5 degrees C for 24 h caused aggregation of seminal proteins in both species. A higher aggregation and loss of proteins were observed when freezing was done in liquid nitrogen at -196 degrees C. The effect was more pronounced in buffalo than in cattle. Loss of more seminal plasma proteins due to cryoinjury in buffalo semen may account for its poorer freezability than that of cattle semen.

Physical work capacity is reduced in sea level residents--lowlanders (LL) as compared to high altitude residents--highlanders (HL). To determine possible etiologies, cardiac performance was studied in two groups of healthy male volunteers (13 LL and 11 HL) utilizing systolic time intervals during rest, submaximal and maximal exercise. The LL were studied at sea level and subsequently during 10 days of residence at an altitude of 3658 m. The HL were studied at high altitude alone. The LL were restudied 30-45 min after administration of intravenous furosemide at high altitude. Mean maximal oxygen uptake (VO2max) was reduced by 26% in the LL group at high altitude in comparison to sea level values and by 20% in relation to the HL group. Cardiac performance was estimated by the pre-ejection period/left ventricular ejection time ratio. This index was significantly increased in the LL group at high altitude in comparison to sea level values during submaximal and maximal exercise (P less than 0.01). Intravenous furosemide in the LL group increased the heart rate (P less than 0.05) at rest and during exercise but VO2max and cardiac performance were unchanged. It is hypothesized that reduced physical work capacity at high altitude in the LL group may be related to depression of cardiac performance in these subjects. Administration of intravenous furosemide did not influence cardiac performance in the LL group at high altitude.